You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Though its overall diagnostics revenues fell year over year, its molecular diagnostics business had a strong quarter with sales growth of 29 percent.
The new rate applies to clinical diagnostic lab tests using high-throughput technologies that can process more than 200 specimens per day.
The Project Screen initiative aims to provide the Hong Kong community with home access to the World Health Organization-approved RT-PCR test for SARS-CoV-2 at zero profit to its organizers.
In PNAS this week: common variants associated with complement factor H binding, DNA metabarcoding-based study of boreal wetland, and more.
Use of the assay by Finland's main clinical laboratories will double testing capacity and allow test coverage for most of the country, Mobidiag said.
Seegene said Monday that the Health Canada approval will enable hospitals and licensed labs there to run the assay immediately for high-volume testing.
The company's qualitative real-time PCR test detects SARS-CoV-2 from nasal, nasopharyngeal, and oropharyngeal swabs.
The molecular laboratory-developed test was authorized for use only in the Stanford Health Care Clinical Virology Laboratory.
The company said it has recently expanded its manufacturing capacity to 500,000 tests per week and is planning to increase it another fourfold.
The real-time PCR test provides results in about four hours and has been validated on Thermo Fisher Scientific and Bio-Rad instruments.
A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.
US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.
According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.
In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.